Terumo Americas Holding anchors the North American operations of Terumo, the Japanese medical technology group founded in 1972 whose products reach more than 160 countries. From its base in North America - including Somerset, New Jersey, the headquarters of Terumo Medical Corporation - the company develops, manufactures, markets, distributes and sells medical devices and supplies intended to improve patient outcomes and clinical efficiency.
Technical work spans minimally invasive access and intervention, injection and infusion therapy, cardiac surgery, aortic care, health-outcome optimisation, and medical device development and manufacturing, supported by research, clinical training and education programmes. The business is organised across several units: Terumo Interventional Systems (minimally invasive access and interventional technologies), Terumo Medical Products (injection and infusion therapy), Terumo Cardiovascular (cardiac surgery), Terumo Aortic (aortic care), Terumo Health Outcomes (health-outcome optimisation) and the Pharmaceutical Solutions Division.
The portfolio serves industry verticals spanning healthcare, medical devices, cardiovascular surgery, aortic care, interventional medicine, pharmaceutical solutions and clinical outcomes. Engineering, manufacturing and clinical functions work alongside research, training and education teams supporting healthcare professionals.
